메뉴 건너뛰기




Volumn 143, Issue 4, 2015, Pages 471-478

Breast cancer subtypes predispose the site of distant metastases

Author keywords

Breast cancer; Metastasis; Subtype

Indexed keywords

TRASTUZUMAB;

EID: 84930341478     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPYO5FSV3UPEXS     Document Type: Article
Times cited : (202)

References (41)
  • 2
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
    • Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687-1717.
    • (2005) Lancet , vol.365 , pp. 1687-1717
  • 3
    • 33645834966 scopus 로고    scopus 로고
    • Metastatic patterns in adenocarcinoma
    • Hess KR, Varadhachary GR, Taylor SH, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106:1624-1633.
    • (2006) Cancer , vol.106 , pp. 1624-1633
    • Hess, K.R.1    Varadhachary, G.R.2    Taylor, S.H.3
  • 4
    • 0037301972 scopus 로고    scopus 로고
    • Survival of patients with metastatic breast carcinoma: Importance of prognostic markers of the primary tumor
    • Chang J, Clark GM, Allred DC, et al. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer. 2003;97:545-553.
    • (2003) Cancer , vol.97 , pp. 545-553
    • Chang, J.1    Clark, G.M.2    Allred, D.C.3
  • 5
    • 57449098840 scopus 로고    scopus 로고
    • Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers
    • Chia S, Norris B, Speers C, et al. Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers. J Clin Oncol. 2008;26:5697-5704.
    • (2008) J Clin Oncol. , vol.26 , pp. 5697-5704
    • Chia, S.1    Norris, B.2    Speers, C.3
  • 6
    • 0021925411 scopus 로고
    • Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients
    • Alanko A, Heinonen E, Scheinin T, et al. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients. Cancer. 1985;56:1696-1700.
    • (1985) Cancer , vol.56 , pp. 1696-1700
    • Alanko, A.1    Heinonen, E.2    Scheinin, T.3
  • 7
    • 38649109161 scopus 로고    scopus 로고
    • An overview of prognostic factors for long-term survivors of breast cancer
    • Soerjomataram I, Louwman MW, Ribot JG, et al. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 2008;107:309-330.
    • (2008) Breast Cancer Res Treat. , vol.107 , pp. 309-330
    • Soerjomataram, I.1    Louwman, M.W.2    Ribot, J.G.3
  • 8
    • 0024708518 scopus 로고
    • The distribution of secondary growths in cancer of the breast. 1889
    • Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8:98-101.
    • (1989) Cancer Metastasis Rev. , vol.8 , pp. 98-101
    • Paget, S.1
  • 9
    • 0000629930 scopus 로고
    • Selection of successive tumour lines for metastasis
    • Fidler IJ Selection of successive tumour lines for metastasis. Nat New Biol. 1973;242:148-149.
    • (1973) Nat New Biol. , vol.242 , pp. 148-149
    • Fidler, I.J.1
  • 10
    • 48149106931 scopus 로고    scopus 로고
    • Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients
    • Kriege M, Seynaeve C, Meijers-Heijboer H, et al. Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients. Breast Cancer Res Treat. 2008;111(2):303-311.
    • (2008) Breast Cancer Res Treat. , vol.111 , Issue.2 , pp. 303-311
    • Kriege, M.1    Seynaeve, C.2    Meijers-Heijboer, H.3
  • 11
    • 0025779949 scopus 로고
    • Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group
    • Koenders PG, Beex LV, Langens R, et al. Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group. Breast Cancer Res Treat. 1991;18:27-32.
    • (1991) Breast Cancer Res Treat. , vol.18 , pp. 27-32
    • Koenders, P.G.1    Beex, L.V.2    Langens, R.3
  • 12
    • 79952697149 scopus 로고    scopus 로고
    • Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs
    • Wei S, Li Y, Siegal GP, et al. Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs. Ann Diagn Pathol. 2011;15:79-83.
    • (2011) Ann Diagn Pathol. , vol.15 , pp. 79-83
    • Wei, S.1    Li, Y.2    Siegal, G.P.3
  • 13
    • 77953346211 scopus 로고    scopus 로고
    • Breast cancer brain metastases: Differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)
    • Niwinska A, Murawska M, Pogoda K. Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT). Ann Oncol. 2010;21:942-948.
    • (2010) Ann Oncol. , vol.21 , pp. 942-948
    • Niwinska, A.1    Murawska, M.2    Pogoda, K.3
  • 14
    • 77954740501 scopus 로고    scopus 로고
    • Metastatic behavior of breast cancer subtypes
    • Kennecke H, Yerushalmi R, Woods R, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28:3271-3277.
    • (2010) J Clin Oncol. , vol.28 , pp. 3271-3277
    • Kennecke, H.1    Yerushalmi, R.2    Woods, R.3
  • 15
    • 0034680102 scopus 로고    scopus 로고
    • Molecular portraits of human breast tumours
    • Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-752.
    • (2000) Nature , vol.406 , pp. 747-752
    • Perou, C.M.1    Sorlie, T.2    Eisen, M.B.3
  • 16
    • 33744960226 scopus 로고    scopus 로고
    • Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
    • Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492-2502.
    • (2006) JAMA , vol.295 , pp. 2492-2502
    • Carey, L.A.1    Perou, C.M.2    Livasy, C.A.3
  • 17
    • 44849114353 scopus 로고    scopus 로고
    • Subtypes of breast cancer show preferential site of relapse
    • Smid M, Wang YX, Zhang Y, et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res. 2008;68:3108-3114.
    • (2008) Cancer Res. , vol.68 , pp. 3108-3114
    • Smid, M.1    Wang, Y.X.2    Zhang, Y.3
  • 18
    • 23144461051 scopus 로고    scopus 로고
    • Genes that mediate breast cancer metastasis to lung
    • Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436:518-524.
    • (2005) Nature , vol.436 , pp. 518-524
    • Minn, A.J.1    Gupta, G.P.2    Siegel, P.M.3
  • 19
    • 34147211281 scopus 로고    scopus 로고
    • Lung metastasis genes couple breast tumor size and metastatic spread
    • Minn AJ, Gupta GP, Padua D, et al. Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A. 2007;104:6740-6745.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 6740-6745
    • Minn, A.J.1    Gupta, G.P.2    Padua, D.3
  • 20
    • 67649300721 scopus 로고    scopus 로고
    • Genes that mediate breast cancer metastasis to the brain
    • Bos PD, Zhang XHF, Nadal C, et al. Genes that mediate breast cancer metastasis to the brain. Nature. 2009;459:1005-1009.
    • (2009) Nature , vol.459 , pp. 1005-1009
    • Bos, P.D.1    Zhang, X.H.F.2    Nadal, C.3
  • 21
    • 70349728696 scopus 로고    scopus 로고
    • Estrogen and progesterone receptor expression is not always specific for mammary and gynecologic carcinomas: A tissue microarray and pooled literature review study
    • Wei S, Said-Al-Naief N, Hameed O. Estrogen and progesterone receptor expression is not always specific for mammary and gynecologic carcinomas: a tissue microarray and pooled literature review study. Appl Immunohistochem Mol Morphol. 2009;17:393-402.
    • (2009) Appl Immunohistochem Mol Morphol. , vol.17 , pp. 393-402
    • Wei, S.1    Said-Al-Naief, N.2    Hameed, O.3
  • 22
    • 51349157679 scopus 로고    scopus 로고
    • Using a higher cutoff for the percentage of HER2+ cells decreases interobserver variability in the interpretation of HER2 immunohistochemical analysis
    • Hameed O, Adams AL, Baker AC, et al. Using a higher cutoff for the percentage of HER2+ cells decreases interobserver variability in the interpretation of HER2 immunohistochemical analysis. Am J Clin Pathol. 2008;130:425-427.
    • (2008) Am J Clin Pathol. , vol.130 , pp. 425-427
    • Hameed, O.1    Adams, A.L.2    Baker, A.C.3
  • 23
    • 79960980007 scopus 로고    scopus 로고
    • Strategies for subtypes - Dealing with the diversity of breast cancer: Highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
    • Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736-1747.
    • (2011) Ann Oncol. , vol.22 , pp. 1736-1747
    • Goldhirsch, A.1    Wood, W.C.2    Coates, A.S.3
  • 24
    • 84869811250 scopus 로고    scopus 로고
    • Molecular subclasses of breast cancer: How do we define them? The IMPAKT 2012 Working Group Statement
    • Guiu S, Michiels S, Andre F, et al. Molecular subclasses of breast cancer: how do we define them? the IMPAKT 2012 Working Group Statement. Ann Oncol. 2012;23:2997-3006.
    • (2012) Ann Oncol. , vol.23 , pp. 2997-3006
    • Guiu, S.1    Michiels, S.2    Andre, F.3
  • 25
    • 84906805668 scopus 로고    scopus 로고
    • Luminal B breast cancer: Molecular characterization, clinical management, and future perspectives
    • [published online July 21, 2014]
    • Ades F, Zardavas D, Bozovic-Spasojevic I, et al. Luminal B breast cancer: molecular characterization, clinical management, and future perspectives [published online July 21, 2014]. J Clin Oncol.
    • J Clin Oncol.
    • Ades, F.1    Zardavas, D.2    Bozovic-Spasojevic, I.3
  • 26
    • 84879901369 scopus 로고    scopus 로고
    • Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles
    • Gazinska P, Grigoriadis A, Brown JP, et al. Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles. Mod Pathol. 2013;26:955-966.
    • (2013) Mod Pathol. , vol.26 , pp. 955-966
    • Gazinska, P.1    Grigoriadis, A.2    Brown, J.P.3
  • 27
    • 34047217348 scopus 로고    scopus 로고
    • COX-2 involvement in breast cancer metastasis to bone
    • Singh B, Berry JA, Shoher A, et al. COX-2 involvement in breast cancer metastasis to bone. Oncogene. 2007;26:3789-3796.
    • (2007) Oncogene , vol.26 , pp. 3789-3796
    • Singh, B.1    Berry, J.A.2    Shoher, A.3
  • 28
    • 80052666221 scopus 로고    scopus 로고
    • Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: A nationwide cohort study
    • Sihto H, Lundin J, Lundin M, et al. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Res. 2011;13:R87.
    • (2011) Breast Cancer Res. , vol.13 , pp. R87
    • Sihto, H.1    Lundin, J.2    Lundin, M.3
  • 29
    • 7944223780 scopus 로고    scopus 로고
    • Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
    • Li YM, Pan Y, Wei YK, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell. 2004;6:459-469.
    • (2004) Cancer Cell , vol.6 , pp. 459-469
    • Li, Y.M.1    Pan, Y.2    Wei, Y.K.3
  • 31
    • 33646869874 scopus 로고    scopus 로고
    • Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
    • Pestalozzi BC, Zahrieh D, Price KN, et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol. 2006;17:935-944.
    • (2006) Ann Oncol. , vol.17 , pp. 935-944
    • Pestalozzi, B.C.1    Zahrieh, D.2    Price, K.N.3
  • 32
    • 33744813556 scopus 로고    scopus 로고
    • Genes associated with breast cancer metastatic to bone
    • Smid M, Wang Y, Klijn JG, et al. Genes associated with breast cancer metastatic to bone. J Clin Oncol. 2006;24:2261-2267.
    • (2006) J Clin Oncol. , vol.24 , pp. 2261-2267
    • Smid, M.1    Wang, Y.2    Klijn, J.G.3
  • 33
    • 33846459466 scopus 로고    scopus 로고
    • Sorting out breast-cancer gene signatures
    • Massague J. Sorting out breast-cancer gene signatures. N Engl J Med. 2007;356:294-297.
    • (2007) N Engl J Med. , vol.356 , pp. 294-297
    • Massague, J.1
  • 34
    • 84875732582 scopus 로고    scopus 로고
    • Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update
    • Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:961-965.
    • (2013) J Clin Oncol. , vol.31 , pp. 961-965
    • Khatcheressian, J.L.1    Hurley, P.2    Bantug, E.3
  • 35
    • 84863646635 scopus 로고    scopus 로고
    • Adjuvant therapy in stage I carcinoma of the breast: The influence of multigene analyses and molecular phenotyping
    • Schwartz GF, Bartelink H, Burstein HJ, et al. Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping. Breast J. 2012;18:303-311.
    • (2012) Breast J. , vol.18 , pp. 303-311
    • Schwartz, G.F.1    Bartelink, H.2    Burstein, H.J.3
  • 36
    • 84884958436 scopus 로고    scopus 로고
    • Interobserver concordance in implementing the 2010 ASCO/CAP recommendations for reporting ER in breast carcinomas: A demonstration of the difficulties of consistently reporting low levels of ER expression by manual quantification
    • Reisenbichler ES, Lester SC, Richardson AL, et al. Interobserver concordance in implementing the 2010 ASCO/CAP recommendations for reporting ER in breast carcinomas: a demonstration of the difficulties of consistently reporting low levels of ER expression by manual quantification. Am J Clin Pathol. 2013;140:487-494.
    • (2013) Am J Clin Pathol. , vol.140 , pp. 487-494
    • Reisenbichler, E.S.1    Lester, S.C.2    Richardson, A.L.3
  • 37
    • 84890254448 scopus 로고    scopus 로고
    • Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
    • Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997-4013.
    • (2013) J Clin Oncol. , vol.31 , pp. 3997-4013
    • Wolff, A.C.1    Hammond, M.E.2    Hicks, D.G.3
  • 38
    • 84871762532 scopus 로고    scopus 로고
    • Effect of ASCO/CAP guidelines for determining ER status on molecular subtype
    • Deyarmin B, Kane JL, Valente AL, et al. Effect of ASCO/CAP guidelines for determining ER status on molecular subtype. Ann Surg Oncol. 2013;20:87-93.
    • (2013) Ann Surg Oncol. , vol.20 , pp. 87-93
    • Deyarmin, B.1    Kane, J.L.2    Valente, A.L.3
  • 39
    • 42249099793 scopus 로고    scopus 로고
    • Heterogeneity of breast cancer metastases: Comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases
    • Wu JM, Fackler MJ, Halushka MK, et al. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res. 2008;14:1938-1946.
    • (2008) Clin Cancer Res. , vol.14 , pp. 1938-1946
    • Wu, J.M.1    Fackler, M.J.2    Halushka, M.K.3
  • 40
    • 77951952801 scopus 로고    scopus 로고
    • Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
    • Aitken SJ, Thomas JS, Langdon SP, et al. Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Ann Oncol. 2010;21:1254-1261.
    • (2010) Ann Oncol. , vol.21 , pp. 1254-1261
    • Aitken, S.J.1    Thomas, J.S.2    Langdon, S.P.3
  • 41
    • 69849090104 scopus 로고    scopus 로고
    • Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
    • Simmons C, Miller N, Geddie W, et al. Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? Ann Oncol. 2009;20:1499-1504.
    • (2009) Ann Oncol. , vol.20 , pp. 1499-1504
    • Simmons, C.1    Miller, N.2    Geddie, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.